Return-Path: <Catherine.Garbay@imag.fr>
X-Original-To: polytech_liste-egc@sympa.univ-nantes.fr
Delivered-To: polytech_liste-egc@sympa.univ-nantes.fr
Received: from BounceSmtp1.univ-nantes.fr (BounceSMTP1.univ-nantes.prive [172.20.12.66])
	by Sympa.univ-nantes.fr (Postfix) with ESMTP id BA2E16F7A8C
	for <polytech_liste-egc@sympa.univ-nantes.fr>; Thu, 18 Dec 2008 10:56:15 +0100 (CET)
Received: from MX1.univ-nantes.fr (MX1.univ-nantes.fr [193.52.101.135])
	by BounceSmtp1.univ-nantes.fr (Postfix) with ESMTP id A03FFC3BC
	for <polytech_liste-egc@sympa.univ-nantes.fr>; Thu, 18 Dec 2008 10:56:19 +0100 (CET)
Received: from localhost (debian [127.0.0.1])
	by MX1.univ-nantes.fr (Postfix) with ESMTP id AAD8714003FF
	for <polytech_liste-egc@sympa.univ-nantes.fr>; Thu, 18 Dec 2008 10:56:15 +0100 (CET)
Received: from MX1.univ-nantes.fr ([193.52.101.135])
	by localhost (MX1.univ-nantes.fr [193.52.101.135]) (amavisd-new, port 10024)
	with LMTP id 25552-02-87
	for <polytech_liste-egc@sympa.univ-nantes.fr>;
	Thu, 18 Dec 2008 10:56:11 +0100 (CET)
X-Greylist: domain auto-whitelisted by SQLgrey-1.6.7
Received: from imag.imag.fr (imag.imag.fr [129.88.30.1])
	by MX1.univ-nantes.fr (Postfix) with ESMTP id 902F4140041E
	for <liste-egc@polytech.univ-nantes.fr>; Thu, 18 Dec 2008 10:56:11 +0100 (CET)
Received: from clopinette.imag.fr (clopinette.imag.fr [129.88.34.215])
	by imag.imag.fr (8.13.8/8.13.8) with ESMTP id mBI9pLGo026995
	(version=TLSv1/SSLv3 cipher=DHE-RSA-AES256-SHA bits=256 verify=NO)
	for <liste-egc@polytech.univ-nantes.fr>; Thu, 18 Dec 2008 10:51:21 +0100 (CET)
Received: from [10.6.5.169] (garbay-vpn.imag.fr [129.88.61.16])
	by clopinette.imag.fr (8.13.8/8.13.8) with ESMTP id mBI9q3XT009420
	for <liste-egc@polytech.univ-nantes.fr>; Thu, 18 Dec 2008 10:52:04 +0100
Message-Id: <AE1E061F-B55C-4513-B269-F5E02E46F763@imag.fr>
From: Garbay Catherine <Catherine.Garbay@imag.fr>
To: liste-egc@polytech.univ-nantes.fr
Content-Type: multipart/alternative; boundary=Apple-Mail-7-31130683
Mime-Version: 1.0 (Apple Message framework v929.2)
Date: Thu, 18 Dec 2008 10:51:57 +0100
References: <9D2D37E9-2175-4E7F-B141-4B73F8CFF0B0@univr.it>
X-Mailer: Apple Mail (2.929.2)
X-Greylist: Sender IP whitelisted, not delayed by milter-greylist-3.0 (imag.imag.fr [129.88.30.1]); Thu, 18 Dec 2008 10:51:21 +0100 (CET)
X-IMAG-MailScanner-Information: Please contact MI2S MIM for more information
X-IMAG-MailScanner: Found to be clean
X-IMAG-MailScanner-SpamCheck: 
X-IMAG-MailScanner-From: catherine.garbay@imag.fr
Subject: AIME'09 - Artificial Intelligence in Medicine 2009 - Verona. Second cfp
X-Virus-Scanned: by amavisd-new-20030616-p7 (Debian) at univ-nantes.fr
X-CRM114-Version: 20040816.BlameClockworkOrange-auto.3 (regex: TRE TRE 0.7.2 (GPL)) MF-A10FFB4C 
X-CRM114-Status: Good  ( pR: 306.2144 )
X-Spam-Status: No, hits=-3.5 tagged_above=-10000.0 required=5.0
	tests=HTML_30_40, HTML_MESSAGE, J_CHICKENPOX_93, LINES_OF_YELLING,
	LINES_OF_YELLING_2, CRM_HAM_05
X-Spam-Level: 
X-Validation-by: fabrice.guillet@univ-nantes.fr

--Apple-Mail-7-31130683
Content-Type: text/plain;
	charset=US-ASCII;
	format=flowed;
	delsp=yes
Content-Transfer-Encoding: 7bit

AIME'09

Second ...

... Call for Papers
... Call for Workshops
... Call for Tutorials


for the 12th Conference on
Artificial Intelligence in MEdicine

July 18 - 22, 2009, Verona, I
http://www.aimedicine.info/
http://aimedicine.info/aime09/


****************************************



The European Society for Artificial Intelligence in MEdicine (AIME), was
established in 1986 with two main goals: 1) to foster fundamental and  
applied
research in the application of Artificial Intelligence (AI) techniques  
to
medical care and medical research, and 2) to provide a forum for  
reporting
significant results achieved at biennial conferences. A major activity  
of this society
has been a series of international conferences, from Marseille (FR) in  
1987 to
Amsterdam (NL) in 2007, held biennially over the last 20 years.

The AIME'09 conference will be a unique opportunity to present and  
improve the
international state of the art of AI in BioMedicine from both  
perspectives of theory,
methodology, and application. For this purpose, AIME'09 will include  
include invited
lectures, full and short papers, tutorials, workshops,
and a doctoral consortium. The conference will be held in Verona -  
Italy.


INVITED SPEAKERS

Carol Friedman,  Department of Biomedical Informatics, Columbia  
University, U.S.A.
Catherine Garbay, Laboratoire d'Informatique de Grenoble, CNRS, France


SCOPE

Original contributions are sought regarding the development of theory,
techniques, and applications of AI in BioMedicine, including the  
exploitation
of AI approaches to molecular medicine and biomedical informatics.
Contributions to theory may include presentation or
analysis of the properties of novel AI methodologies potentially  
useful to
solve biomedical problems. Papers on techniques should describe the  
development or
the extension of AI methods and their implementation, and discuss the
assumptions and limitations of the proposed methods. Application  
papers should
describe the implementation of AI systems to solve significant medical
problems, and should present sufficient information to allow  
evaluation of the
practical benefits of the system.

Original long and short papers are sought on the development of theory,
systems, and applications of AI in Medicine, including the exploitation
of AI approaches to molecular medicine and biomedical informatics and
to healthcare organizational aspects.
Contributions to theory may include presentation or analysis of the
properties of novel AI methods potentially useful in solving medical
problems. Papers addressing theory should describe the development or
the extension of AI methods and discuss the assumptions and limitations
of the proposed methods and their novelty with respect to the state of
the art. Papers addressing systems should describe the requirements,
design and implementation of new AI-inspired tools and systems, and
discuss their applicability in the medical field. Application papers
should describe the implementation of AI systems to solve significant
medical problems, and should present sufficient information to allow
evaluation of the practical benefits of the system.

The scope of the conference includes the following areas:
* Knowledge Acquisition and Management
* Machine Learning, Knowledge Discovery and Data Mining
* Biomedical Ontologies and Terminologies
* Decision Support Systems
* Neural Networks and Belief Networks
* Reasoning under Uncertainty
* Temporal and Spatial Representation and Reasoning
* Case-Based Reasoning
* Planning and Scheduling
* Protocols and Guidelines
* Information Retrieval
* Natural Language Generation and Understanding
* Biomedical Computer Vision, Imaging, and Signal Interpretation
* Intelligent Agents
* Telemedicine and Cooperative Systems
* Cognitive Modelling
* Healthcare Process Management


SUBMISSIONS OVERVIEW

There are two categories of paper submission
1. Full research papers (up to 10 pages)
2. Short papers (up to 5 pages) that are
a. short reasearch paper
b. demonstration of implemented systems
c. late-breaking results (work-in-progress)

Papers should be formatted according to Springer's LNCS format (see
www.springeronline.com/lncs or www.springer.de/comp/lncs/ 
authors.html). Authors
are strongly encouraged to submit the papers electronically, following  
the
instructions provided in the conference web page (see below).

All accepted papers will appear in the conference proceedings which  
will be
published as part of Springer's "Lecture Notes in AI" series. In  
addition, the
authors of the best submissions will be invited to expand and refine  
their
papers for possible publication in the journal Artificial Intelligence  
in
Medicine (Elsevier).
As in previous AIME conferences, proposals for the organisation of  
tutorials
and satellite workshops are sought regarding any of the above topic  
areas.


IMPORTANT DATES

Proposals for Tutorials:  February 9, 2009
Proposals for Workshops:  February 9, 2009
Electronic Draft Abstract Submission Deadline:  February 2, 2009
Electronic Paper Submission Deadline:  February 9, 2009
Notification of Acceptance:  April 6, 2009
Camera-Ready Copy Deadline:  April 27, 2009
For more details about the conference please consult: http://aimedicine.info/aime09/


Yuval Shahar, Beer Sheva, Israel (Programme Committee co-Chair)
Carlo Combi, Verona, Italy (Programme Committee co-Chair and
Organizing Committee Chair)


PROGRAMME COMMITTEE

Ameen Abu-Hanna, The Netherlands (Doctoral Consortium Chair)
Klaus-Peter Adlassnig, Austria
Steen Andreassen, Denmark
Pedro Barahona, Portugal
Riccardo Bellazzi, Italy
Petr Berka, Czech Republic
Isabelle Bichindaritz, USA
Paul de Clercq, The Netherlands
Carlo Combi, Italy (Local Chair and Scientific co-Chair)
Michel Dojat, France
Henrik Eriksson, Sweden
Catherine Garbay, France
Peter Haddawy, Thailand
Arie Hasman, The Netherlands
Reinhold Haux, Germany
John Holmes, USA
Werner Horn, Austria
Jim Hunter, UK
Hidde de Jong, France
Elpida Keravnou, Cyprus
Pedro Larranaga, Spain
Nada Lavrac, Slovenia
Xiaohui Liu, UK
Peter Lucas, The Netherlands
Roque Marin, Spain
Paola Mello, Italy
Gloria Menegaz, Italy
Silvia Miksch, Austria
Stefania Montani, Italy
Mark Musen, USA
Barbara Oliboni, Italy
Niels Peek, The Netherlands
Mor Peleg, Israel
Christian Popow, Austria
Silvana Quaglini, Italy
Marco Ramoni, USA
Alan Rector, UK
Stephen Rees, Denmark
Lucia Sacchi, Italy
Rainer Schmidt, Germany
Brigitte Seroussi, France
Yuval Shahar, Israel (Scientific co-Chair)
Basilio Sierra, Spain
Costas Spyropoulos, Greece
Mario Stefanelli, Italy
Paolo Terenziani, Italy
Samson Tu, USA
Allan Tucker, UK
Frans Voorbraak, The Netherlands
Dongwen Wang, USA
Thomas Wetter, Germany
Blaz Zupan, Slovenia
Pierre Zweigenbaum, France


ORGANIZING COMMITTEE

Carlo Combi, Italy
Barbara Oliboni, Italy
Roberto Posenato, Italy
Gabriele Pozzani, Italy



------------
Catherine Garbay - DR CNRS
Directeur adjoint - Laboratoire d'Informatique de Grenoble
06 72 94 62 38 - 04 76 51 43 76
http://lig.imag.fr/perso/garbay/


--Apple-Mail-7-31130683
Content-Type: text/html;
	charset=US-ASCII
Content-Transfer-Encoding: quoted-printable

<html><body style=3D"word-wrap: break-word; -webkit-nbsp-mode: space; -webk=
it-line-break: after-white-space; "><div><div>AIME'09</div><div style=3D"wo=
rd-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-wh=
ite-space; "><div><div><div><br></div><div>Second ...</div><div><br></div><=
div>... Call for Papers</div><div>... Call for Workshops</div><div>... Call=
 for Tutorials</div><div><br></div><div><br></div><div>for the 12th Confere=
nce on</div><div>Artificial Intelligence in MEdicine</div><div><br></div><d=
iv>July 18 - 22, 2009, Verona, I</div><div><a href=3D"http://www.aimedicine=
.info/">http://www.aimedicine.info/</a></div><div><a href=3D"http://aimedic=
ine.info/aime09/">http://aimedicine.info/aime09/</a></div><div><br></div><d=
iv><br></div><div>****************************************</div><div><br></=
div><div><br></div><div><br></div><div>The European Society for Artificial =
Intelligence in MEdicine (AIME), was</div><div>established in 1986 with two=
 main goals: 1) to foster fundamental and applied</div><div>research in the=
 application of Artificial Intelligence (AI) techniques to</div><div>medica=
l care and medical research, and 2) to provide a forum for reporting</div><=
div>significant results achieved at biennial conferences. A major activity =
of this society</div><div>has been a series of international conferences, f=
rom Marseille (FR) in 1987 to</div><div>Amsterdam (NL) in 2007, held bienni=
ally over the last 20 years.</div><div><br></div><div>The AIME'09 conferenc=
e will be a unique opportunity to present and improve the</div><div>interna=
tional state of the art of AI in BioMedicine from both perspectives of theo=
ry,</div><div>methodology, and application. For this purpose, AIME'09 will =
include include invited</div><div>lectures, full and short papers, tutorial=
s, workshops,</div><div>and a doctoral consortium. The conference will be h=
eld in Verona - Italy.</div><div><br></div><div><br></div><div>INVITED SPEA=
KERS</div><div><br></div><div>Carol Friedman, &nbsp;Department of Biomedica=
l Informatics, Columbia University, U.S.A.</div><div>Catherine Garbay, Labo=
ratoire d'Informatique de Grenoble, CNRS, France</div><div><br></div><div><=
br></div><div>SCOPE</div><div><br></div><div>Original contributions are sou=
ght regarding the development of theory,</div><div>techniques, and applicat=
ions of AI in BioMedicine, including the exploitation</div><div>of AI appro=
aches to molecular medicine and biomedical informatics.</div><div>Contribut=
ions to theory may include presentation or</div><div>analysis of the proper=
ties of novel AI methodologies potentially useful to</div><div>solve biomed=
ical problems. Papers on techniques should describe the development or</div=
><div>the extension of AI methods and their implementation, and discuss the=
</div><div>assumptions and limitations of the proposed methods. Application=
 papers should</div><div>describe the implementation of AI systems to solve=
 significant medical</div><div>problems, and should present sufficient info=
rmation to allow evaluation of the</div><div>practical benefits of the syst=
em.</div><div><br></div><div>Original long and short papers are sought on t=
he development of theory,</div><div>systems, and applications of AI in Medi=
cine, including the exploitation</div><div>of AI approaches to molecular me=
dicine and biomedical informatics and</div><div>to healthcare organizationa=
l aspects.</div><div>Contributions to theory may include presentation or an=
alysis of the</div><div>properties of novel AI methods potentially useful i=
n solving medical</div><div>problems. Papers addressing theory should descr=
ibe the development or</div><div>the extension of AI methods and discuss th=
e assumptions and limitations</div><div>of the proposed methods and their n=
ovelty with respect to the state of</div><div>the art. Papers addressing sy=
stems should describe the requirements,</div><div>design and implementation=
 of new AI-inspired tools and systems, and</div><div>discuss their applicab=
ility in the medical field. Application papers</div><div>should describe th=
e implementation of AI systems to solve significant</div><div>medical probl=
ems, and should present sufficient information to allow</div><div>evaluatio=
n of the practical benefits of the system.</div><div><br></div><div>The sco=
pe of the conference includes the following areas:</div><div>* Knowledge Ac=
quisition and Management</div><div>* Machine Learning, Knowledge Discovery =
and Data Mining</div><div>* Biomedical Ontologies and Terminologies</div><d=
iv>* Decision Support Systems</div><div>* Neural Networks and Belief Networ=
ks</div><div>* Reasoning under Uncertainty</div><div>* Temporal and Spatial=
 Representation and Reasoning</div><div>* Case-Based Reasoning</div><div>* =
Planning and Scheduling</div><div>* Protocols and Guidelines</div><div>* In=
formation Retrieval</div><div>* Natural Language Generation and Understandi=
ng</div><div>* Biomedical Computer Vision, Imaging, and Signal Interpretati=
on</div><div>* Intelligent Agents</div><div>* Telemedicine and Cooperative =
Systems</div><div>* Cognitive Modelling</div><div>* Healthcare Process Mana=
gement</div><div><br></div><div><br></div><div>SUBMISSIONS OVERVIEW</div><d=
iv><br></div><div>There are two categories of paper submission</div><div>1.=
 Full research papers (up to 10 pages)</div><div>2. Short papers (up to 5 p=
ages) that are</div><div>a. short reasearch paper</div><div>b. demonstratio=
n of implemented systems</div><div>c. late-breaking results (work-in-progre=
ss)</div><div><br></div><div>Papers should be formatted according to Spring=
er's LNCS format (see</div><div><a href=3D"http://www.springeronline.com/ln=
cs">www.springeronline.com/lncs</a> or <a href=3D"http://www.springer.de/co=
mp/lncs/authors.html)">www.springer.de/comp/lncs/authors.html)</a>. Authors=
</div><div>are strongly encouraged to submit the papers electronically, fol=
lowing the</div><div>instructions provided in the conference web page (see =
below).</div><div><br></div><div>All accepted papers will appear in the con=
ference proceedings which will be</div><div>published as part of Springer's=
 "Lecture Notes in AI" series. In addition, the</div><div>authors of the be=
st submissions will be invited to expand and refine their</div><div>papers =
for possible publication in the journal Artificial Intelligence in</div><di=
v>Medicine (Elsevier).</div><div>As in previous AIME conferences, proposals=
 for the organisation of tutorials</div><div>and satellite workshops are so=
ught regarding any of the above topic areas.</div><div><br></div><div><br><=
/div><div>IMPORTANT DATES</div><div><br></div><div>Proposals for Tutorials:=
 &nbsp;February 9, 2009</div><div>Proposals for Workshops: &nbsp;February 9=
, 2009</div><div>Electronic Draft Abstract Submission Deadline: &nbsp;Febru=
ary 2, 2009</div><div>Electronic Paper Submission Deadline: &nbsp;February =
9, 2009</div><div>Notification of Acceptance: &nbsp;April 6, 2009</div><div=
>Camera-Ready Copy Deadline: &nbsp;April 27, 2009</div><div>For more detail=
s about the conference please consult: <a href=3D"http://aimedicine.info/ai=
me09/">http://aimedicine.info/aime09/</a></div><div><br></div><div><br></di=
v><div>Yuval Shahar, Beer Sheva, Israel (Programme Committee co-Chair)</div=
><div>Carlo Combi, Verona, Italy (Programme Committee co-Chair and</div><di=
v>Organizing Committee Chair)</div><div><br></div><div><br></div><div>PROGR=
AMME COMMITTEE</div><div><br></div><div>Ameen Abu-Hanna, The Netherlands (D=
octoral Consortium Chair)</div><div>Klaus-Peter Adlassnig, Austria</div><di=
v>Steen Andreassen, Denmark</div><div>Pedro Barahona, Portugal</div><div>Ri=
ccardo Bellazzi, Italy</div><div>Petr Berka, Czech Republic</div><div>Isabe=
lle Bichindaritz, USA</div><div>Paul de Clercq, The Netherlands</div><div>C=
arlo Combi, Italy (Local Chair and Scientific co-Chair)</div><div>Michel Do=
jat, France</div><div>Henrik Eriksson, Sweden</div><div>Catherine Garbay, F=
rance</div><div>Peter Haddawy, Thailand</div><div>Arie Hasman, The Netherla=
nds</div><div>Reinhold Haux, Germany</div><div>John Holmes, USA</div><div>W=
erner Horn, Austria</div><div>Jim Hunter, UK&nbsp;</div><div>Hidde de Jong,=
 France</div><div>Elpida Keravnou, Cyprus</div><div>Pedro Larranaga, Spain<=
/div><div>Nada Lavrac, Slovenia</div><div>Xiaohui Liu, UK</div><div>Peter L=
ucas, The Netherlands</div><div>Roque Marin, Spain</div><div>Paola Mello, I=
taly</div><div>Gloria Menegaz, Italy</div><div>Silvia Miksch, Austria</div>=
<div>Stefania Montani, Italy</div><div>Mark Musen, USA</div><div>Barbara Ol=
iboni, Italy</div><div>Niels Peek, The Netherlands</div><div>Mor Peleg, Isr=
ael</div><div>Christian Popow, Austria</div><div>Silvana Quaglini, Italy</d=
iv><div>Marco Ramoni, USA</div><div>Alan Rector, UK</div><div>Stephen Rees,=
 Denmark</div><div>Lucia Sacchi, Italy</div><div>Rainer Schmidt, Germany</d=
iv><div>Brigitte Seroussi, France</div><div>Yuval Shahar, Israel (Scientifi=
c co-Chair)</div><div>Basilio Sierra, Spain</div><div>Costas Spyropoulos, G=
reece</div><div>Mario Stefanelli, Italy</div><div>Paolo Terenziani, Italy</=
div><div>Samson Tu, USA</div><div>Allan Tucker, UK</div><div>Frans Voorbraa=
k, The Netherlands</div><div>Dongwen Wang, USA</div><div>Thomas Wetter, Ger=
many</div><div>Blaz Zupan, Slovenia</div><div>Pierre Zweigenbaum, France</d=
iv><div><br></div><div><br></div><div>ORGANIZING COMMITTEE</div><div><br></=
div><div>Carlo Combi, Italy</div><div>Barbara Oliboni, Italy</div><div>Robe=
rto Posenato, Italy</div><div>Gabriele Pozzani, Italy</div></div></div></di=
v></div><br><div apple-content-edited=3D"true"> <span class=3D"Apple-style-=
span" style=3D"border-collapse: separate; border-spacing: 0px 0px; color: r=
gb(0, 0, 0); font-family: Helvetica; font-size: 12px; font-style: normal; f=
ont-variant: normal; font-weight: normal; letter-spacing: normal; line-heig=
ht: normal; text-align: auto; -khtml-text-decorations-in-effect: none; text=
-indent: 0px; -apple-text-size-adjust: auto; text-transform: none; orphans:=
 2; white-space: normal; widows: 2; word-spacing: 0px; "><div style=3D"word=
-wrap: break-word; -khtml-nbsp-mode: space; -khtml-line-break: after-white-=
space; "><span class=3D"Apple-style-span" style=3D"border-collapse: separat=
e; border-spacing: 0px 0px; color: rgb(0, 0, 0); font-family: Helvetica; fo=
nt-size: 12px; font-style: normal; font-variant: normal; font-weight: norma=
l; letter-spacing: normal; line-height: normal; text-align: auto; -khtml-te=
xt-decorations-in-effect: none; text-indent: 0px; -apple-text-size-adjust: =
auto; text-transform: none; orphans: 2; white-space: normal; widows: 2; wor=
d-spacing: 0px; "><span class=3D"Apple-style-span" style=3D"border-collapse=
: separate; border-spacing: 0px 0px; color: rgb(0, 0, 0); font-family: Helv=
etica; font-size: 12px; font-style: normal; font-variant: normal; font-weig=
ht: normal; letter-spacing: normal; line-height: normal; text-align: auto; =
-khtml-text-decorations-in-effect: none; text-indent: 0px; -apple-text-size=
-adjust: auto; text-transform: none; orphans: 2; white-space: normal; widow=
s: 2; word-spacing: 0px; "><span class=3D"Apple-style-span" style=3D"border=
-collapse: separate; border-spacing: 0px 0px; color: rgb(0, 0, 0); font-fam=
ily: Helvetica; font-size: 12px; font-style: normal; font-variant: normal; =
font-weight: normal; letter-spacing: normal; line-height: normal; text-alig=
n: auto; -khtml-text-decorations-in-effect: none; text-indent: 0px; -apple-=
text-size-adjust: auto; text-transform: none; orphans: 2; white-space: norm=
al; widows: 2; word-spacing: 0px; "><span class=3D"Apple-style-span" style=
=3D"border-collapse: separate; border-spacing: 0px 0px; color: rgb(0, 0, 0)=
; font-family: Helvetica; font-size: 12px; font-style: normal; font-variant=
: normal; font-weight: normal; letter-spacing: normal; line-height: normal;=
 text-align: auto; -khtml-text-decorations-in-effect: none; text-indent: 0p=
x; -apple-text-size-adjust: auto; text-transform: none; orphans: 2; white-s=
pace: normal; widows: 2; word-spacing: 0px; "><br class=3D"Apple-interchang=
e-newline"><div style=3D"margin-top: 0px; margin-right: 0px; margin-bottom:=
 0px; margin-left: 0px; "><br class=3D"khtml-block-placeholder"></div><div =
style=3D"margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-lef=
t: 0px; ">------------</div><div style=3D"margin-top: 0px; margin-right: 0p=
x; margin-bottom: 0px; margin-left: 0px; ">Catherine Garbay - DR CNRS</div>=
<div style=3D"margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margi=
n-left: 0px; ">Directeur adjoint - Laboratoire d'Informatique de Grenoble</=
div><div style=3D"margin-top: 0px; margin-right: 0px; margin-bottom: 0px; m=
argin-left: 0px; ">06 72 94 62 38 -&nbsp;04 76 51 43 76</div><a href=3D"htt=
p://lig.imag.fr/perso/garbay/"><span class=3D"Apple-style-span" style=3D"co=
lor: rgb(0, 0, 238); -khtml-text-decorations-in-effect: underline; ">http:/=
/lig.imag.fr/perso/garbay/</span></a><br class=3D"Apple-interchange-newline=
"></span></span></span></span></div></span> </div><br></body></html>=

--Apple-Mail-7-31130683--

